{"Images": [{"Name": "i0", "Description": "Human Colon Adenocarcinoma (FFPE) ", "Path": "images/ColonACImmune", "Width": 2000, "Height": 2000, "MaxLevel": 0}], "Header": "Tissue was stained with Human IO IMC panel and Immune expansion IMC panel following heat-mediated antigen retrieval performed using Tris/EDTA buffer pH 9. Image size 2,000 x 2,000 \u00b5m.\n", "Rotation": 0, "Layout": {"Grid": [["i0"]]}, "Stories": [{"Name": "", "Description": "", "Waypoints": [{"Name": "Immune infiltration and TLS detection", "Description": "Human Colon Adenocarcinoma (FFPE) shows extensive immune infiltration in tumor stroma (vimentin) including presence of multiple Tertiary lymphoid structures (TLS).  TLS are the lymphocyte aggregates (including T cells (CD3), B cells CD20 and dendritic cells (CD14)) that play a key role in the anti-tumor immune response in solid tumors. \n\n\n", "Arrows": [], "Overlays": [], "Group": "PD-L1 check point marker ", "Masks": [], "ActiveMasks": [], "Zoom": 0.5626474442988204, "Pan": [0.5, 0.5]}, {"Name": "Expression of PD-L1 check point marker ", "Description": "Human Colon Adenocarcinoma (FFPE) shows expression of PD-L1 in tumor cells (PanCK) and macrophages (CD68). Immune checkpoints occur when proteins on the surface of T cells recognize and bind to immune checkpoint proteins such as PD-L1on other cells, including tumor cells and macrophages. Binding results in an \u201coff\u201d signal being sent to the T cells (CD3), preventing the them from destroying the cancer cells. Checkpoint inhibitor, immunotherapy drugs block this interaction of checkpoint proteins, allowing the T cells to kill the cancer cells. \n", "Arrows": [], "Overlays": [], "Group": "PD-L1 check point marker ", "Masks": [], "ActiveMasks": [], "Zoom": 0.44905857740585775, "Pan": [0.5, 0.4257182920730896]}, {"Name": "Inflammation and proliferation", "Description": "Human Colon Adenocarcinoma (FFPE) shows areas of inflammation (inducible Nitric Oxide Synthase, iNOS) in tumor Stroma and extensive proliferation in tumor cells (PanCK) and other cells (including TLS). iNOS plays a significant role in the immune system generating NO which acts as a signaling molecule. Myeloperoxidase (MPO) expression, a local mediator of inflammation is also observed. Ki-67 indicates active proliferation of tumor cells (PanCK) and immune cells (CD45).\n", "Arrows": [], "Overlays": [], "Group": "Inflammation and proliferation", "Masks": [], "ActiveMasks": [], "Zoom": 0.44905857740585775, "Pan": [0.5000000000000002, 0.54218696200088]}, {"Name": "CAF", "Description": "Human Colon Adenocarcinoma (FFPE) has high expression of Carcinoma associated fibroblasts (CAFs). CAFs have recently been implicated in neoplastic progression, tumor growth, angiogenesis, and metastasis of epithelial solid tumors.  CAFs can be identified by markers like aSMA, FAP, collagen I, podoplanin and vimentin, which are commonly used to distinguish them from other fibroblast populations. aSMA (alpha-Smooth Muscle Actin) is a marker of myofibroblasts, often found in the tumor microenvironment (TME). FAP is a serine protease involved in extracellular matrix remodeling and fibrogenesis, potentially accelerating tumor progression. Podoplanin is a transmembrane sialomucin-like glycoprotein that is upregulated in several cancers promoting invasiveness. Collagen I is another extracellular matrix (ECM) protein used to identify CAFS. Vimentin characterizes cells of a mesenchymal phenotype.  \n", "Arrows": [], "Overlays": [], "Group": "Carcinoma associated fibroblasts -CAFs", "Masks": [], "ActiveMasks": [], "Zoom": 0.9604705821581697, "Pan": [0.8883097199605982, 0.28468430897318553]}]}], "Channels": [{"Rendered": false, "Name": "170Er_CD3(Er170Di)", "Path": "170Er-CD3Er170Di_39__170Er-CD3Er170Di"}, {"Rendered": false, "Name": "115In_CD20(In115Di)", "Path": "115In-CD20In115Di_5__115In-CD20In115Di"}, {"Rendered": false, "Name": "149Sm_Vimentin(Sm149Di)", "Path": "149Sm-VimentinSm149Di_19__149Sm-VimentinSm149Di"}, {"Rendered": false, "Name": "191Ir_DNA1(Ir191Di)", "Path": "191Ir-DNA1Ir191Di_47__191Ir-DNA1Ir191Di"}, {"Rendered": false, "Name": "175Lu_CD14(Lu175Di)", "Path": "175Lu-CD14Lu175Di_44__175Lu-CD14Lu175Di"}, {"Rendered": false, "Name": "141Pr_pan CK(Pr141Di)", "Path": "141Pr-pan-CKPr141Di_11__141Pr-pan-CKPr141Di"}, {"Rendered": false, "Name": "159Tb_CD68(Tb159Di)", "Path": "159Tb-CD68Tb159Di_28__159Tb-CD68Tb159Di"}, {"Rendered": false, "Name": "166Er_PD-L1 (Er166Di)", "Path": "166Er-PD-L1-Er166Di_35__166Er-PD-L1-Er166Di"}, {"Rendered": false, "Name": "89Y_Collagen I(Y89Di)", "Path": "89Y-Collagen-IY89Di_2__89Y-Collagen-IY89Di"}, {"Rendered": false, "Name": "152Sm_CD45(Sm152Di)", "Path": "152Sm-CD45Sm152Di_22__152Sm-CD45Sm152Di"}, {"Rendered": false, "Name": "150Nd_Ki-67 (Nd150Di)", "Path": "150Nd-Ki-67-Nd150Di_20__150Nd-Ki-67-Nd150Di"}, {"Rendered": false, "Name": "148Nd_MPO(Nd148Di)", "Path": "148Nd-MPONd148Di_18__148Nd-MPONd148Di"}, {"Rendered": false, "Name": "168Er_iNOS(Er168Di)", "Path": "168Er-iNOSEr168Di_37__168Er-iNOSEr168Di"}, {"Rendered": false, "Name": "161Dy_FAP(Dy161Di)", "Path": "161Dy-FAPDy161Di_30__161Dy-FAPDy161Di"}, {"Rendered": false, "Name": "164Dy_Podoplanin(Dy164Di)", "Path": "164Dy-PodoplaninDy164Di_33__164Dy-PodoplaninDy164Di"}, {"Rendered": false, "Name": "209Bi_aSMA(Bi209Di)", "Path": "209Bi-aSMABi209Di_54__209Bi-aSMABi209Di"}], "Masks": [], "Groups": [{"Name": "TLS", "Colors": ["ff0000", "00ffff", "ff00ff", "0000ff", "00ff00"], "Channels": ["170Er_CD3(Er170Di)", "115In_CD20(In115Di)", "149Sm_Vimentin(Sm149Di)", "191Ir_DNA1(Ir191Di)", "175Lu_CD14(Lu175Di)"], "Descriptions": ["", "", "", "", ""]}, {"Name": "PD-L1 check point marker ", "Colors": ["0000ff", "ff0000", "00ff00", "ff00ff", "ffffff"], "Channels": ["141Pr_pan CK(Pr141Di)", "159Tb_CD68(Tb159Di)", "166Er_PD-L1 (Er166Di)", "170Er_CD3(Er170Di)", "89Y_Collagen I(Y89Di)"], "Descriptions": ["", "", "", "", ""]}, {"Name": "Inflammation and proliferation", "Colors": ["0000ff", "00ff00", "ff00ff", "00ffff", "ff0000"], "Channels": ["141Pr_pan CK(Pr141Di)", "152Sm_CD45(Sm152Di)", "150Nd_Ki-67 (Nd150Di)", "148Nd_MPO(Nd148Di)", "168Er_iNOS(Er168Di)"], "Descriptions": ["", "", "", "", ""]}, {"Name": "Carcinoma associated fibroblasts -CAFs", "Colors": ["0000ff", "00ff00", "ff0000", "ff00ff", "00ffff"], "Channels": ["89Y_Collagen I(Y89Di)", "161Dy_FAP(Dy161Di)", "164Dy_Podoplanin(Dy164Di)", "149Sm_Vimentin(Sm149Di)", "209Bi_aSMA(Bi209Di)"], "Descriptions": ["", "", "", "", ""]}], "PixelsPerMicron": 1, "FirstGroup": "Overview", "FirstViewport": {"Pan": [0.09540726524034554, 0.6756601890958541], "Zoom": 1.29328870292887}}
